My Cart [ 0 ]
Home > Cell Biology > Stable Cell Lines > Perjeta / Omnitarg Biosimilar Stable Cell Line

Perjeta / Omnitarg Biosimilar Stable Cell Line

Pertuzumab, 2C4, Anti-HER2 Humanized Monoclonal Antibody
Catalog No. Product Name Size List Price (US$) Quantity
C006 Perjeta / Omnitarg Biosimilar Stable Cell Line 1 package Request
Description

Pertuzumab (2C4, trade name Perjeta, Omnitarg, Genentech), a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.

C006: Perjeta / Omnitarg Biosimilar Stable Cell Line (CHO)

The yield of Perjeta / Omnitarg biosimilar from the CHO stable cell line was above 3.0 g/L in a 3 liter manufacturing.

The Perjeta / Omnitarg biosimilar stable cell line alone can be transferred alone or together with the technology of process development and/or antibody purification.

Syd Labs also provides the following anti-ErbB/HER antibody biosimilar stable cell lines:
Herceptin Biosimilar Stable Cell Line (HER2, ErbB-2, c-neu)
Erbitux Biosimilar Stable Cell Line (HER1, ErbB-1, EGFR)
Vectibix Biosimilar Stable Cell Line (HER1, ErbB-1, EGFR)

Related Links

Super savings and terrific tips sent to your email inbox:

See our Privacy Policy